Literature DB >> 31066004

Transperineal ultrasound for assessment of fistulas and abscesses: a pictorial essay.

Alessandra Lavazza1, Giovanni Maconi2.   

Abstract

Perianal fistulas and abscesses may be cryptogenetic or associated with inflammatory bowel disease (IBD), specifically Crohn's disease. Proper identification and classification of these lesions are paramount for correct therapeutic management. Current diagnostic modalities include MRI (magnetic resonance imaging), EUS (endoscopic ultrasound), EUA (exam under anaesthesia) and recently, transperineal ultrasound (TPUS). The latter has been proposed as a noninvasive, easily available and cost-effective technique to diagnose, assess and follow up perianal disease particularly in IBD patients. This pictorial review focuses on the role of TPUS in clinical practice, highlighting the features of fistulas and abscesses.

Entities:  

Keywords:  Abscess; Clinical practice; Fistula; Perianal ultrasound; Pictorial review

Mesh:

Year:  2019        PMID: 31066004      PMCID: PMC6531524          DOI: 10.1007/s40477-019-00381-6

Source DB:  PubMed          Journal:  J Ultrasound        ISSN: 1876-7931


  14 in total

1.  Infliximab for the treatment of fistulas in patients with Crohn's disease.

Authors:  D H Present; P Rutgeerts; S Targan; S B Hanauer; L Mayer; R A van Hogezand; D K Podolsky; B E Sands; T Braakman; K L DeWoody; T F Schaible; S J van Deventer
Journal:  N Engl J Med       Date:  1999-05-06       Impact factor: 91.245

2.  A classification of fistula-in-ano.

Authors:  A G Parks; P H Gordon; J D Hardcastle
Journal:  Br J Surg       Date:  1976-01       Impact factor: 6.939

3.  Endosonographic elastography of the anal sphincter in patients with fecal incontinence.

Authors:  H Allgayer; A Ignee; C F Dietrich
Journal:  Scand J Gastroenterol       Date:  2010       Impact factor: 2.423

Review 4.  New horizons in the imaging of perianal Crohn's disease: transperineal ultrasonography.

Authors:  Cristina Bezzio; Robert V Bryant; Gianpiero Manes; Giovanni Maconi; Simone Saibeni
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2017-03-28       Impact factor: 3.869

5.  Sonography of the cervix during the third trimester of pregnancy: value of the transperineal approach.

Authors:  B S Hertzberg; J D Bowie; T M Weber; B A Carroll; M A Kliewer; S G Jordan
Journal:  AJR Am J Roentgenol       Date:  1991-07       Impact factor: 3.959

6.  Clinical and radiological responses after infliximab treatment for perianal fistulizing Crohn's disease.

Authors:  Imran Rasul; Stephanie R Wilson; Helen MacRae; Sue Irwin; Gordon R Greenberg
Journal:  Am J Gastroenterol       Date:  2004-01       Impact factor: 10.864

7.  Transperineal ultrasonography: First level exam in IBD patients with perianal disease.

Authors:  Fulvia Terracciano; Giuseppe Scalisi; Fabrizio Bossa; Daniela Scimeca; Giuseppe Biscaglia; Michele Mangiacotti; Maria Rosa Valvano; Francesco Perri; Anna Simeone; Angelo Andriulli
Journal:  Dig Liver Dis       Date:  2016-04-26       Impact factor: 4.088

8.  Are there specific endosonographic features in Crohn's patients with perianal fistulae?

Authors:  Andrew P Zbar; Nir Horesh; Vered Bucholtz; Oded Zmora; Marc Beer-Gabel; Dan Carter
Journal:  J Crohns Colitis       Date:  2012-08-21       Impact factor: 9.071

9.  Morphological characterisation of Crohn's disease fistulae.

Authors:  F Bataille; F Klebl; P Rümmele; J Schroeder; S Farkas; P-J Wild; A Fürst; F Hofstädter; J Schölmerich; H Herfarth; G Rogler
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

10.  Assessing the activity of perianal Crohn's disease: comparison of clinical indices and computer-assisted anal ultrasound.

Authors:  Alessandra Losco; Chiara Viganò; Dario Conte; Bruno Mario Cesana; Guido Basilisco
Journal:  Inflamm Bowel Dis       Date:  2009-05       Impact factor: 5.325

View more
  1 in total

Review 1.  Ultrasonography in inflammatory bowel disease - So far we are?

Authors:  Maaser Christian; Maconi Giovanni; Kucharzik Torsten; Allocca Mariangela
Journal:  United European Gastroenterol J       Date:  2022-02-08       Impact factor: 4.623

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.